product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
BRM Antibody
catalog :
6889S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat, dog
application :
western blot
citations: 2
Published Application/Species/DilutionReference
  • western blot (knockdown validation); rat; 1:2000; fig 5
  • western blot; human; 1:2000; fig 2
  • western blot; mouse; 1:2000; fig 2
McKenna B, Guo M, Reynolds A, Hara M, Stein R. Dynamic recruitment of functionally distinct Swi/Snf chromatin remodeling complexes modulates Pdx1 activity in islet β cells. Cell Rep. 2015;10:2032-42 pubmed publisher
  • western blot; human
WILSON B, Helming K, Wang X, Kim Y, Vazquez F, Jagani Z, et al. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Mol Cell Biol. 2014;34:1136-44 pubmed publisher
product information
SKU :
6889S
Product-Name :
BRM Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk, (Dg)
Applications :
Western blot
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
200
Host :
Rabbit
Target :
BRM
Primary-Protein :
SMARCA2
Alt-Names :
ATP-dependent helicase SMARCA2,BAF190,BAF190B,BRG1-associated factor 190B,BRM,FLJ36757,MGC74511,Probable global transcription activator SNF2L2,Protein brahma homolog,SMARCA2,SMCA2,SNF2,SNF2-alpha,SNF2-like 2,SNF2/SWI2-like protein 2,SNF2A,SNF2L2,SNF2LA,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2,SWI2,Sth1p,global transcription activator homologous sequence,hBRM,hSNF2a,sucrose nonfermenting 2-like protein 2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.